157 related articles for article (PubMed ID: 36557923)
1. ML216-Induced BLM Helicase Inhibition Sensitizes PCa Cells to the DNA-Crosslinking Agent Cisplatin.
Ma XY; Zhao JF; Ruan Y; Zhang WM; Zhang LQ; Cai ZD; Xu HQ
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557923
[TBL] [Abstract][Full Text] [Related]
2. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair.
Kong Y; Xu C; Sun X; Sun H; Zhao X; He N; Ji K; Wang Q; Du L; Wang J; Zhang M; Liu Y; Wang Y; Liu Q
Cancer Biol Med; 2021 Dec; 19(8):1150-71. PubMed ID: 34846107
[TBL] [Abstract][Full Text] [Related]
3. Centipeda minima extract sensitizes lung cancer cells to DNA-crosslinking agents via targeting Fanconi anemia pathway.
Fan XZ; Chen YF; Zhang SB; He DH; Wei SF; Wang Q; Pan HF; Liu YQ
Phytomedicine; 2021 Oct; 91():153689. PubMed ID: 34446320
[TBL] [Abstract][Full Text] [Related]
4. Aberrant BLM cytoplasmic expression associates with DNA damage stress and hypersensitivity to DNA-damaging agents in colorectal cancer.
Votino C; Laudanna C; Parcesepe P; Giordano G; Remo A; Manfrin E; Pancione M
J Gastroenterol; 2017 Mar; 52(3):327-340. PubMed ID: 27169843
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a Novel Bloom's Syndrome Protein (BLM) Inhibitor Suppressing Growth and Metastasis of Prostate Cancer.
Ma XY; Xu HQ; Zhao JF; Ruan Y; Chen B
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499126
[TBL] [Abstract][Full Text] [Related]
6. The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance.
Ovejero S; Viziteu E; Dutrieux L; Devin J; Lin YL; Alaterre E; Jourdan M; Basbous J; Requirand G; Robert N; de Boussac H; Seckinger A; Hose D; Vincent L; Herbaux C; Constantinou A; Pasero P; Moreaux J
Front Immunol; 2022; 13():983181. PubMed ID: 36569948
[TBL] [Abstract][Full Text] [Related]
7. A small molecule inhibitor of the BLM helicase modulates chromosome stability in human cells.
Nguyen GH; Dexheimer TS; Rosenthal AS; Chu WK; Singh DK; Mosedale G; Bachrati CZ; Schultz L; Sakurai M; Savitsky P; Abu M; McHugh PJ; Bohr VA; Harris CC; Jadhav A; Gileadi O; Maloney DJ; Simeonov A; Hickson ID
Chem Biol; 2013 Jan; 20(1):55-62. PubMed ID: 23352139
[TBL] [Abstract][Full Text] [Related]
8. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin.
Shi Y; Felley-Bosco E; Marti TM; Orlowski K; Pruschy M; Stahel RA
BMC Cancer; 2012 Dec; 12():571. PubMed ID: 23211021
[TBL] [Abstract][Full Text] [Related]
9. PARP1 negatively regulates transcription of BLM through its interaction with HSP90AB1 in prostate cancer.
Huang M; Chen L; Guo Y; Ruan Y; Xu H
J Transl Med; 2023 Jul; 21(1):445. PubMed ID: 37415147
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of BLM RecQ helicase inhibits proliferation, promotes the apoptosis and enhances the sensitivity of bladder cancer cells to cisplatin.
Feng S; Qian X; Feng D; Zhang X
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 36004459
[TBL] [Abstract][Full Text] [Related]
11. YM155 sensitizes ovarian cancer cells to cisplatin inducing apoptosis and tumor regression.
Mir R; Stanzani E; Martinez-Soler F; Villanueva A; Vidal A; Condom E; Ponce J; Gil J; Tortosa A; Giménez-Bonafé P
Gynecol Oncol; 2014 Jan; 132(1):211-20. PubMed ID: 24262875
[TBL] [Abstract][Full Text] [Related]
12. DNA damage response (DDR) pathway engagement in cisplatin radiosensitization of non-small cell lung cancer.
Sears CR; Cooney SA; Chin-Sinex H; Mendonca MS; Turchi JJ
DNA Repair (Amst); 2016 Apr; 40():35-46. PubMed ID: 26991853
[TBL] [Abstract][Full Text] [Related]
13. Elucidation of DNA Repair Function of PfBlm and Potentiation of Artemisinin Action by a Small-Molecule Inhibitor of RecQ Helicase.
Suthram N; Padhi S; Jha P; Bhattacharyya S; Bulusu G; Roy A; Bhattacharyya MK
mSphere; 2020 Nov; 5(6):. PubMed ID: 33239368
[TBL] [Abstract][Full Text] [Related]
14. The human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage.
Mao FJ; Sidorova JM; Lauper JM; Emond MJ; Monnat RJ
Cancer Res; 2010 Aug; 70(16):6548-55. PubMed ID: 20663905
[TBL] [Abstract][Full Text] [Related]
15. DNA double-strand breaks repair inhibitors potentiates the combined effect of VP-16 and CDDP in human colorectal adenocarcinoma (LoVo) cells.
Kopa P; Macieja A; Pastwa E; Majsterek I; Poplawski T
Mol Biol Rep; 2021 Jan; 48(1):709-720. PubMed ID: 33389482
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 attenuates cisplatin-induced gammaH2AX formation and DNA double-strand breaks repair pathway in non-small cell lung cancer.
Jeon JH; Kim SK; Kim HJ; Chang J; Ahn CM; Chang YS
Cancer Lett; 2008 Dec; 272(2):232-41. PubMed ID: 18762365
[TBL] [Abstract][Full Text] [Related]
17. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3.
Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG
Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894
[TBL] [Abstract][Full Text] [Related]
18. ML216 Prevents DNA Damage-Induced Senescence by Modulating DBC1-BLM Interaction.
Cui F; Han X; Zhang X; Wang S; Liang N; Tan Q; Sha W; Li J
Cells; 2022 Dec; 12(1):. PubMed ID: 36611939
[TBL] [Abstract][Full Text] [Related]
19. Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin Uptake.
Piro G; Roca MS; Bruzzese F; Carbone C; Iannelli F; Leone A; Volpe MG; Budillon A; Di Gennaro E
Mol Cancer Ther; 2019 Aug; 18(8):1405-1417. PubMed ID: 31189612
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
